全文获取类型
收费全文 | 2890篇 |
免费 | 214篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 80篇 |
妇产科学 | 58篇 |
基础医学 | 300篇 |
口腔科学 | 117篇 |
临床医学 | 301篇 |
内科学 | 726篇 |
皮肤病学 | 90篇 |
神经病学 | 246篇 |
特种医学 | 115篇 |
外科学 | 264篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 226篇 |
眼科学 | 69篇 |
药学 | 177篇 |
中国医学 | 4篇 |
肿瘤学 | 300篇 |
出版年
2024年 | 4篇 |
2023年 | 29篇 |
2022年 | 49篇 |
2021年 | 139篇 |
2020年 | 96篇 |
2019年 | 107篇 |
2018年 | 133篇 |
2017年 | 80篇 |
2016年 | 91篇 |
2015年 | 109篇 |
2014年 | 119篇 |
2013年 | 163篇 |
2012年 | 249篇 |
2011年 | 287篇 |
2010年 | 135篇 |
2009年 | 116篇 |
2008年 | 202篇 |
2007年 | 220篇 |
2006年 | 173篇 |
2005年 | 159篇 |
2004年 | 132篇 |
2003年 | 117篇 |
2002年 | 112篇 |
2001年 | 10篇 |
2000年 | 10篇 |
1999年 | 9篇 |
1998年 | 14篇 |
1997年 | 12篇 |
1996年 | 15篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1983年 | 1篇 |
1977年 | 1篇 |
1960年 | 1篇 |
1938年 | 1篇 |
排序方式: 共有3116条查询结果,搜索用时 904 毫秒
131.
132.
Ourania Kolliniati Eleftheria Ieronymaki Eleni Vergadi Christos Tsatsanis 《Journal of innate immunity》2022,14(1):51
Macrophages, the central mediators of innate immune responses, being in the first-line of defense, they have to readily respond to pathogenic or tissue damage signals to initiate the inflammatory cascade. Such rapid responses require energy to support orchestrated production of pro-inflammatory mediators and activation of phagocytosis. Being a cell type that is present in diverse environments and conditions, macrophages have to adapt to different nutritional resources. Thus, macrophages have developed plasticity and are capable of utilizing energy at both normoxic and hypoxic conditions and in the presence of varying concentrations of glucose or other nutrients. Such adaptation is reflected on changes in signaling pathways that modulate responses, accounting for the different activation phenotypes observed. Macrophage metabolism has been tightly associated with distinct activation phenotypes within the range of M1-like and M2-like types. In the context of diseases, systemic changes also affect macrophage metabolism, as in diabetes and insulin resistance, which results in altered metabolism and distinct activation phenotypes in the adipose tissue or in the periphery. In the context of solid tumors, tumor-associated macrophages adapt in the hypoxic environment, which results in metabolic changes that are reflected on an activation phenotype that supports tumor growth. Coordination of environmental and pathogenic signals determines macrophage metabolism, which in turn shapes the type and magnitude of the response. Therefore, modulating macrophage metabolism provides a potential therapeutic approach for inflammatory diseases and cancer. 相似文献
133.
Dimitrios Farmakis Pavlos Papakotoulas Eleni Angelopoulou Theodoros Bischiniotis George Giannakoulas Panagiotis Kliridis Dimitrios Richter Ioannis Paraskevaidis 《Oncology Letters》2022,23(4)
Atrial fibrillation (AF) may often pre-exist in patients with newly diagnosed cancer or occur with increased frequency shortly after cancer diagnosis. Patients with active cancer and AF have a particularly high risk of thromboembolic complications, as both conditions carry a risk of thrombosis. Thromboembolic risk is determined by several factors, including advanced age, sex (females), cancer histology (adenocarcinomas), location (e.g., pancreas, stomach), advanced stage, anticancer regimens (e.g., platinum compounds, anti-angiogenic therapies, immune modulators), comorbidities (e.g., obesity, kidney disease) and concurrent therapies (e.g., surgery, central catheters). Physicians are often reluctant to prescribe anticoagulants to patients with active cancer and AF, mainly due to fear of bleeding complications, which is partly related to the paucity of evidence in the field. Decision making regarding anticoagulation for the prevention of ischemic stroke and systemic embolism in patients with active cancer and AF may be challenging and should not simply rely on the risk prediction scores used in the general AF population. By contrast, the administration and choice of anticoagulants should be based on the comprehensive, individualized and periodic evaluation of thromboembolic and bleeding risk, drug-drug interactions, patient preferences and access to therapies. 相似文献
134.
Athina Christopoulou Alexandros Ardavanis Christos Papandreou Georgios Koumakis Georgios Papatsimpas Pavlos Papakotoulas Nikolaos Tsoukalas Charalambos Andreadis Georgios Samelis Pavlos Papakostas Gerasimos Aravantinos Nikolaos Ziras Maria Souggleri Charalambos Kalofonos Epameinondas Samantas Paris Makrantonakis Georgios Pentheroudakis Athanasios Athanasiadis Helen Stergiou Alexandros Bokas Anastasios Grivas Elli-Sofia Tripodaki Ioannis Varthalitis Eleni Timotheadou Ioannis Boukovinas 《Oncology Letters》2022,23(4)
Thromboprophylaxis, as a preventive measure for cancer-associated thrombosis (CAT), may be beneficial for patients with active cancer and high-risk for thrombosis. The present post hoc analysis include a total of 407 patients enrolled in the Greek Management of Thrombosis study, who received thromboprophylaxis with tinzaparin. The objectives of the present analysis were: i) To obtain sufficient evidence for the administration of prophylaxis in patients with active cancer, irrespective of Khorana risk assessment model score; ii) to identify the selection criteria for both dose and duration of tinzaparin; and iii) to evaluate the efficacy and safety of tinzaparin administered for CAT prophylaxis. The main tumor types for the patients included in the present study were as follows: Lung (25.1%), pancreatic (14.3%), breast (9.1%), stomach (8.4%), colorectal (7.9%) and ovarian (7.6%). Furthermore, metastatic disease was observed in 69.5% of the patients. High thrombotic burden agents (HTBAs) were administered to 66.3% of the patients, and 17.4% received erythropoietin. A total of 43.7% of the patients exhibited a Khorana score <2. The results of the present study demonstrated that both the presence of metastatic disease and the use of HTBAs seemed to influence oncologists'' decisions for the use of thromboprophylaxis in patients with active cancer, regardless of Khorana score. Tinzaparin, in dose expressed in the standard notation for heparins, i.e., anti-Xa factor international units (Anti-Xa IU), was administered at an intermediate dose (InterD; 8,000-12,000 Anti-Xa IU; once daily) to 52.4% of patients, while the remaining patients received a prophylactic dose (ProD; ≤4,500 Anti-Xa IU; once daily). The average duration of thromoprophylaxis was 5 months. Furthermore, a total of 14 (3.4%) thrombotic events and 6 (1.5%) minor bleeding events were recorded. A total of four thrombotic events were observed following an InterD treatment of tinzaparin, while 10 thrombotic events were observed following ProD treatment. The present study also demonstrated that an InterD of tinzaparin was administered more frequently to patients with a body mass index >30 kg/m2, a history of smoking and a history of metastatic disease, along with administration of erythropoietin. InterD tinzaparin treatment was found to be potentially more efficacious and without safety concerns. The present study is a registered clinical trial (ClinicalTrials.gov code, ; registration date, September 25, 2017). NCT03292107相似文献
135.
136.
Sakellari Evanthia Vasiliou Eleni Konstantinou Christall Chrisanthou Antri Georgiou Anna Papadini Milena Vlachou Vasso Sapountzi-Krepia Despina 《International journal of mental health and addiction》2020,18(5):1458-1465
International Journal of Mental Health and Addiction - The purpose of this study was to explore the relationship between anxiety, self-esteem, and depression among students of economic sciences and... 相似文献
137.
138.
139.
Francesca Zoratto Clelia Buccheri Romina Mura Luisa Altabella Marion Vanneste Marie Villotte Giovanni Laviola Francois Dauphin Eleni Paizanis Walter Adriani Rossella Canese 《Synapse (New York, N.Y.)》2020,74(4):e22138
We aimed at the further characterization of rats in which SERT gene silencing was achieved by hippocampal injection of a lentiviral vector, carrying three si-RNA to block SERT mRNA at 66% of normal levels. Improved self-control and reduced restlessness were already demonstrated in these rats. Present further studies consisted of male adult rats, bilaterally inoculated within the hippocampus; control rats received lentivirus particles inactivated with heat. Both groups were maintained in isolation for 5 months, starting from inoculation. Neurochemical changes were studied by proton magnetic resonance spectroscopy (1H-MRS): we found increased hippocampal viability and bioenergetic potential; however, rats showed a behaviorally depressive pattern, also characterized by enhanced affiliation. Based on the extent of such effects, the whole lenti-SERT group was divided into two subgroups, termed intermediate- and extreme- phenotype profiles. While all rats had a widespread modification within dorsal/ventral striatum, amygdala, and hypothalamus, only the former subgroup showed an involvement of Raphé medialis, while, for the latter subgroup, an increase of SERT within hippocampus was unexpectedly caused. Within the less-affected “intermediate” rats, hippocampal 5-HT7 receptors were down-modulated, and also similarly within substantia nigra, septum, and neocortex. This picture demonstrates that additional rather than fewer neurobiological changes accompany a lower phenotypic expression. Overall, tapping hippocampal SERT affected the balance between habits versus strategies of coping by promoting morphogenetic processes indicative of a serotonergic fiber plasticity. Supplementary studies about serotonergic dynamics and neurogenesis within fronto-striatal circuits are needed. 相似文献
140.
Zumel-Marne Angela Kundi Michael Castaño-Vinyals Gemma Alguacil Juan Petridou Eleni Th Georgakis Marios K. Morales-Suárez-Varela Maria Sadetzki Siegal Piro Sara Nagrani Rajini Filippini Graziella Hutter Hans-Peter Dikshit Rajesh Woehrer Adelheid Maule Milena Weinmann Tobias Krewski Daniel ′t Mannetje Andrea Momoli Franco Lacour Brigitte Mattioli Stefano Spinelli John J. Ritvo Paul Remen Thomas Kojimahara Noriko Eng Amanda Thurston Angela Lim Hyungryul Ha Mina Yamaguchi Naohito Mohipp Charmaine Bouka Evdoxia Eastman Chelsea Vermeulen Roel Kromhout Hans Cardis Elisabeth 《Journal of neuro-oncology》2020,147(2):427-440
Journal of Neuro-Oncology - We used data from MOBI-Kids, a 14-country international collaborative case–control study of brain tumors (BTs), to study clinical characteristics of the tumors in... 相似文献